Applied DNA Sciences, Inc.
APDN
$3.03
-$0.23-7.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.25% | 51.61% | -44.36% | 10.81% | -30.63% |
| Total Depreciation and Amortization | -83.36% | -88.35% | -75.66% | -58.72% | -40.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.43% | 91.25% | 120.19% | -1,303.02% | 42.85% |
| Change in Net Operating Assets | -516.24% | -183.13% | -121.62% | -132.34% | -88.06% |
| Cash from Operations | 25.73% | -20.32% | -74.91% | -120.52% | -93.37% |
| Capital Expenditure | 48.04% | 55.67% | 55.91% | 66.16% | -104.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 29.94% | 36.87% | 54.00% | 62.78% | -132.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 111.59% | 111.59% | 20,165.35% | -- | -78.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -50.58% | 491.34% | 56,339.03% | -- | -1.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,052.12% | 140.20% | 167.69% | 90.15% | -104.60% |